Access the full text.
Sign up today, get DeepDyve free for 14 days.
J. McCullough, M. Clay, D. Hurd, K. Richards, C. Ludvigsen, L. Forstrom (1986)
Effect of leukocyte antibodies and HLA matching on the intravascular recovery, survival, and tissue localization of 111-indium granulocytes.Blood, 67 2
D. Winston, W. Ho, R. Gale (1982)
Therapeutic granulocyte transfusions for documented infections. A controlled trial in ninety-five infectious granulocytopenic episodes.Annals of internal medicine, 97 4
D. Adkins, G. Spitzer, M. Johnston, W. Velasquez, F. Dunphy, P. Petruska (1997)
Transfusions of granulocyte‐colony‐stimulating factor‐mobilized granulocyte components to allogeneic transplant recipients: analysis of kinetics and factors determining posttransfusion neutrophil and platelet countsTransfusion, 37
D. Stroncek, M. Clay, M. Petzoldt, J. Smith, W. Jaszcz, F. Oldham, J. McCullough (1996)
Treatment of normal individuals with granulocyte‐colony‐stimulating factor: donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cellsTransfusion, 36
J. Alavi, R. Root, I. Djerassi, A. Evans, S. Gluckman, R. Macgregor, D. Guerry, A. Schreiber, J. Shaw, P. Koch, R. Cooper (1977)
A randomized clinical trial of granulocyte transfusions for infection in acute leukemia.The New England journal of medicine, 296 13
S. Albelda, G. Talbot, S. Gerson, W. Miller, P. Cassileth (1985)
Pulmonary cavitation and massive hemoptysis in invasive pulmonary aspergillosis. Influence of bone marrow recovery in patients with acute leukemia.The American review of respiratory disease, 131 1
R. Herzig, Geoffrey Herzig, R. Graw, Bull Mi, Karyl Ray (1977)
Successful granulocyte transfusion therapy for gram-negative septicemia. A prospectively randomized controlled study.The New England journal of medicine, 296 13
C. Peters, M. Minkov, S. Matthes‐Martin, U. Pötschger, V. Witt, G. Mann, P. Höcker, N. Worel, J. Starý, T. Klingebiel, H. Gadner (1999)
Leucocyte transfusions from rhG‐CSF or prednisolone stimulated donors for treatment of severe infections in immunocompromised neutropenic patientsBritish Journal of Haematology, 106
F. Colotta, F. Re, A. Mantovani (1993)
Granulocyte transfusions from granulocyte colony-stimulating factor-treated donors: also a question of cell survival?Blood, 82 7
C. Begley, F. A., Lopez, A. N., Nicola, J. D., Warren, A. M., Vadas, J. C., Sanderson, D., Metcalf (1986)
Purified colony-stimulating factors enhance the survival of human neutrophils and eosinophils in vitro: a rapid and sensitive microassay for colony-stimulating factors.Blood, 68 1
Janice, P., Dutcher, Charles, A., Schiffer, G. Johnston, Dottie, Papenburg, Peter, Daly, Joseph, Aisner (1983)
Alloimmunization prevents the migration of transfused indium-111-labeled granulocytes to sites of infection.Blood, 62 2
E. Vamvakas, A. Pineda (1996)
Meta‐analysis of clinical studies of the efficacy of granulocyte transfusions in the treatment of bacterial sepsisJournal of Clinical Apheresis, 11
D. Higby, J. Yates, E. Henderson, J. Holland (1975)
Filtration leukapheresis for granulocyte transfusion therapy. Clinical and laboratory studies.The New England journal of medicine, 292 15
I. Fortuny, Clara Bloomfield, D. Hadlock, Anne Goldman, B. Kennedy, J. McCullough (2003)
Granulocyte Transfusion: A Controlled Study in Patients with Acute Nonlymphocytic LeukemiaTransfusion, 15
Robert Graw, GP Herzig, Seymour Perry, Edward Henderson (1972)
Normal granulocyte transfusion therapy: treatment of septicemia due to gram-negative bacteria.The New England journal of medicine, 287 8
E. Vamvakas, A. Pineda (1997)
Determinants of the efficacy of prophylactic granulocyte transfusions: A meta‐analysisJournal of Clinical Apheresis, 12
R. Strauss (1993)
Therapeutic granulocyte transfusions in 1993.Blood, 81 7
R. Graw, F. Stout, R. Herzig, G. Herzig (1977)
Granulocyte transfusion therapy for life-threatening bacteremia: results of transfusion trials at the National Cancer Institute.Progress in clinical and biological research, 13
P. Anderlini, Donna Przepiorka, D. Seong, P. Miller, J. Sundberg, Benjamin Lichtiger, F. Norfleet, K. Chan, R. Champlin, M. Korbling (1996)
Clinical toxicity and laboratory effects of granulocyte‐colony‐ stimulating factor (filgrastim) mobilization and blood stem cell apheresis from normal donors, and analysis of charges for the proceduresTransfusion, 36
M. Harada, K. Nagafuji, T. Fujisaki, A. Kubota, S. Mizuno, K. Takenaka, T. Miyamoto, Y. Ohno, H. Gondo, M. Kuroiwa, T. Okamura, S. Inaba, Y. Niho (1996)
G-CSF-induced mobilization of peripheral blood stem cells from healthy adults for allogeneic transplantation.Journal of hematotherapy, 5 1
S. Bhatia, J. McCullough, E. Perry, M. Clay, NK Ramsay, JP Neglia (1994)
Granulocyte transfusions: efficacy in treating fungal infections in neutropenic patients following bone marrow transplantationTransfusion, 34
Hulya Ozsahin, M. Planta, Irene Müller, Hans Steinert, David Nadal, Roger Lauener, Peter Tuchschmid, Ulrich Willi, Mahmut Ozsahin, Nigel Crompton, Reinhard Seger (1998)
Successful treatment of invasive aspergillosis in chronic granulomatous disease by bone marrow transplantation, granulocyte colony-stimulating factor-mobilized granulocytes, and liposomal amphotericin-B.Blood, 92 8
D. Stroncek, K. Leonard, G. Eiber, H. Malech, J. Gallin, S. Leitman (1996)
Alloimmunization after granulocyte transfusionsTransfusion, 36
D. Adkins, H. Goodgold, L. Hendershott, M. Johnston, D. Cravens, G. Spitzer (1997)
Indium-labeled white blood cells apheresed from donors receiving G-CSF localize to sites of inflammation when infused into allogeneic bone marrow transplant recipientsBone Marrow Transplantation, 19
W. Vogler, E. Winton (1977)
A controlled study of the efficacy of granulocyte transfusions in patients with neutropenia.The American journal of medicine, 63 4
G. Bodey, M. Buckley, Y. Sathe, E. Freireich (1966)
Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia.Annals of internal medicine, 64 2
C. Waller, F. Lintig, A. Daskalakis, V. Musahl, W. Lange (1999)
Mobilization of peripheral blood progenitor cells in patients with breast cancer: a prospective randomized trial comparing rhG-CSF with the combination of rhG-CSF plus rhEpo after VIP-E chemotherapyBone Marrow Transplantation, 24
F. Colotta, F. Re, N. Polentarutti, S. Sozzani, A. Mantovani (1992)
Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products.Blood, 80 8
Andrew Maksymiuk, S. Thongprasert, R. Hopfer, M. Luna, V. Fainstein, Gerald Bodey (1984)
Systemic candidiasis in cancer patients.The American journal of medicine, 77 4D
Bacterial and fungal infections are the main cause of morbidity and mortality in neutropenic patients. To resolve infections, an adequate number of functional granulocytes is required. Successful treatment of severe infections with granulocyte transfusions is strongly dependent on an adequate number of transfused cells. In this study, 42 neutropenic patients received rhG-CSF-stimulated granulocyte transfusions (GTXs). Of these patients, 18 with severe infections during neutropenia and 8 in a high-risk situation, as defined by severe infections during previous periods of neutropenia or increasing infectious parameters during prolonged neutropenia, received a median of three GTXs (range 1–25), containing a median total of 2.62×10 10 leukocytes (range 0.3–8.61×10 10 ). A further 16 patients in a pilot study received prophylactic GTX, consisting of a median of three GTXs (range 1–4) containing a median total of 3.20×10 10 leukocytes (range 0.73–8.51×10 10 ). Out of 18 patients with severe infections, 12 improved clinically or showed a resolution of infection after GTX. All 8 patients in a high-risk situation showed a stable clinical course without serious infections. Prophylactic GTX did not result in significant differences with regard to infectious parameters. The median number of transfused platelet units during the course of cytopenia was significantly reduced (13.5 units vs 22.0 units, P <0.02) compared to the control group. For the treatment of infections during neutropenia, rhG-CSF-stimulated granulocyte transfusions are safe and a promising approach.
Annals of Hematology – Springer Journals
Published: May 1, 2002
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.